Wilton Ferreira Silva Santos1, Ana Paula de Castro Cantuária2, Daniele de Castro Félix2, Leandro Kegler Nardes3, Igor Cabral Santos de Melo4. 1. Immunology Division, Sabin Diagnostic Medicine, SAAN QUADRA 03 Lote - 165 Térreo, Brasília, DF, CEP: 70632-300, Brazil. wiltonss@uol.com.br. 2. Immunology Division, Sabin Diagnostic Medicine, SAAN QUADRA 03 Lote - 165 Térreo, Brasília, DF, CEP: 70632-300, Brazil. 3. Escola Superior de Ciências da Saúde-Curso de Medicina, Brasília, Brazil. 4. Unievangélica University, Anápolis, GO, Brazil.
Abstract
BACKGROUND: The prevalence of anti-cell autoantibodies detected by indirect immunofluorescence assay on HEp-2 cells (HEp-2-IIFA) increases with age and is higher in female sex. The number of medical specialties that use HEp-2-IIFA in the investigation of autoimmune diseases has increased lately. This study aimed to determine the prevalence and patterns of autoantibodies on HEp-2-IIFA according to demographics variables and referring medical specialties. METHODS: A retrospective analysis of the HEp-2-IIFA carried out between January and June of 2017 was performed. The International Consensus on Antinuclear Antibodies Patterns (ICAP) and the Brazilian Consensus on Autoantibodies were used for patterns definition on visual reading of the slides. Anti-cell (AC) codes from ICAP and Brazilian AC codes (BAC) were used for patterns classification. RESULTS: From 54,990 samples referred for HEp-2-IIF testing, 20.9% were positive at titer ≥ 1/80. HEp-2-IIFA positivity in females and males was 24% and 12%, respectively (p < 0.0001). The proportion of positive results in the 4 age groups analyzed: 0-19, 20-39, 40-59, and ≥ 60 years was 23.3, 20.2, 20.1, and 22.8%, respectively (p < 0.0001). Considering all positive sera (n = 11,478), AC-4 nuclear fine speckled (37.7%), AC-2 nuclear dense fine speckled (21.3%), BAC-3 nuclear quasi-homogeneous (10%) and mixed/composite patterns (8.8%) were the most prevalent patterns. The specialties that most requested HEp-2-IIFA were general practitioner (20.1%), dermatology (15%), gynecology (9.9%), rheumatology (8.5%), and cardiology (5.8%). HEp-2-IIFA positivity was higher in patients referred by rheumatologists (35.7% vs. 19.6%) (p < 0.0001). Moderate (46.4%) and high (10.8%) titers were more observed in patients referred by rheumatologists (p < 0.0001). We observed a high proportion of mixed and cytoplasmic patterns in samples referred by oncologists and a high proportion of BAC-3 (nuclear quasi-homogeneous) pattern in samples referred by pneumologists. CONCLUSIONS: One-fifth of the patients studied were HEp-2-IIFA-positive. The age groups with more positive results were 0-19 and ≥ 60 years. AC-4, AC-2, BAC-3 and mixed/composite patterns were the most frequent patterns observed. Rheumatologists requested only 8.5% of HEp-2-IIFA. Positive results and moderate to high titers of autoantibodies were more frequent in patients referred by rheumatologists.
BACKGROUND: The prevalence of anti-cell autoantibodies detected by indirect immunofluorescence assay on HEp-2 cells (HEp-2-IIFA) increases with age and is higher in female sex. The number of medical specialties that use HEp-2-IIFA in the investigation of autoimmune diseases has increased lately. This study aimed to determine the prevalence and patterns of autoantibodies on HEp-2-IIFA according to demographics variables and referring medical specialties. METHODS: A retrospective analysis of the HEp-2-IIFA carried out between January and June of 2017 was performed. The International Consensus on Antinuclear Antibodies Patterns (ICAP) and the Brazilian Consensus on Autoantibodies were used for patterns definition on visual reading of the slides. Anti-cell (AC) codes from ICAP and Brazilian AC codes (BAC) were used for patterns classification. RESULTS: From 54,990 samples referred for HEp-2-IIF testing, 20.9% were positive at titer ≥ 1/80. HEp-2-IIFA positivity in females and males was 24% and 12%, respectively (p < 0.0001). The proportion of positive results in the 4 age groups analyzed: 0-19, 20-39, 40-59, and ≥ 60 years was 23.3, 20.2, 20.1, and 22.8%, respectively (p < 0.0001). Considering all positive sera (n = 11,478), AC-4 nuclear fine speckled (37.7%), AC-2 nuclear dense fine speckled (21.3%), BAC-3 nuclear quasi-homogeneous (10%) and mixed/composite patterns (8.8%) were the most prevalent patterns. The specialties that most requested HEp-2-IIFA were general practitioner (20.1%), dermatology (15%), gynecology (9.9%), rheumatology (8.5%), and cardiology (5.8%). HEp-2-IIFA positivity was higher in patients referred by rheumatologists (35.7% vs. 19.6%) (p < 0.0001). Moderate (46.4%) and high (10.8%) titers were more observed in patients referred by rheumatologists (p < 0.0001). We observed a high proportion of mixed and cytoplasmic patterns in samples referred by oncologists and a high proportion of BAC-3 (nuclear quasi-homogeneous) pattern in samples referred by pneumologists. CONCLUSIONS: One-fifth of the patients studied were HEp-2-IIFA-positive. The age groups with more positive results were 0-19 and ≥ 60 years. AC-4, AC-2, BAC-3 and mixed/composite patterns were the most frequent patterns observed. Rheumatologists requested only 8.5% of HEp-2-IIFA. Positive results and moderate to high titers of autoantibodies were more frequent in patients referred by rheumatologists.
Authors: Henrique A Mariz; Emília I Sato; Silvia H Barbosa; Silvia H Rodrigues; Alessandra Dellavance; Luis E C Andrade Journal: Arthritis Rheum Date: 2011-01
Authors: Wilson de Melo Cruvinel; Luis Eduardo Coelho Andrade; Carlos Alberto von Mühlen; Alessandra Dellavance; Antônio Carlos Ximenes; Carlos David Bichara; Cleonice Bueno; Cristóvão Luis Pitangueira Mangueira; Eloísa Bonfá; Fabiano de Almeida Brito; Fernanda Bull Flumian; Glaucielen Gomes da Silva; Jozelia Rêgo; Lisiane Maria Ericoni Dos Anjos; Natasha Slhessarenko; Sandra Gofinet Pasoto; Suzane Pretti Figueiredo Neves; Valéria Valim; Wilton Silva Dos Santos; Paulo Luiz Carvalho Francescantonio Journal: Adv Rheumatol Date: 2019-07-03
Authors: Nancy Agmon-Levin; Jan Damoiseaux; Cees Kallenberg; Ulrich Sack; Torsten Witte; Manfred Herold; Xavier Bossuyt; Lucille Musset; Ricard Cervera; Aresio Plaza-Lopez; Carlos Dias; Maria José Sousa; Antonella Radice; Catharina Eriksson; Olof Hultgren; Markku Viander; Munther Khamashta; Stephan Regenass; Luis Eduardo Coelho Andrade; Allan Wiik; Angela Tincani; Johan Rönnelid; Donald B Bloch; Marvin J Fritzler; Edward K L Chan; I Garcia-De La Torre; Konstantin N Konstantinov; Robert Lahita; Merlin Wilson; Olli Vainio; Nicole Fabien; Renato Alberto Sinico; Pierluigi Meroni; Yehuda Shoenfeld Journal: Ann Rheum Dis Date: 2013-10-14 Impact factor: 19.103
Authors: Luis E C Andrade; Werner Klotz; Manfred Herold; Karsten Conrad; Johan Rönnelid; Marvin J Fritzler; Carlos A von Mühlen; Minoru Satoh; Jan Damoiseaux; Wilson de Melo Cruvinel; Edward K L Chan Journal: Clin Chem Lab Med Date: 2018-09-25 Impact factor: 3.694
Authors: Gregg E Dinse; Christine G Parks; Clarice R Weinberg; Caroll A Co; Jesse Wilkerson; Darryl C Zeldin; Edward K L Chan; Frederick W Miller Journal: Arthritis Rheumatol Date: 2020-04-30 Impact factor: 15.483
Authors: Jan Damoiseaux; Carlos A von Mühlen; Ignacio Garcia-De La Torre; Orlando Gabriel Carballo; Wilson de Melo Cruvinel; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Manfred Herold; Tsuneyo Mimori; Minoru Satoh; Luis E C Andrade; Edward K L Chan; Karsten Conrad Journal: Auto Immun Highlights Date: 2016-01-30